Akebia Therapeutics (AKBA) PT Raised to $18 at Needham & Company
Tweet Send to a Friend
Needham & Company raised its price target on Akebia Therapeutics (NASDAQ: AKBA) to $18.00 (from $14.00) while ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE